On 23 June 2025, the European Academy of Neurology (EAN) and the Brain Health Mission welcomed a diverse audience of citizens, patients, carers, educators, professionals and advocates to the Public Brain Health Day in Helsinki.
Here you will find news from the EAN as well as updates on their activities.
-
-
EAN NewsEAN Congress newsTop ArticlesFeatured SliderEAN 2025 Presidential Symposium: bridging neuroscience frontiers from theory to clinical impact
The EAN 2025 Presidential Symposium in Helsinki explored the latest frontiers of neuroscience - from theoretical models of brain function to cutting-edge insights on multiple sclerosis, neurodegeneration, sleep physiology and movement disorders. -
EAN NewsEAN Congress newsTop ArticlesFeatured SliderEAN 2025 Opening Session kicks off with visionary roadmap for the future of European neurology
The 11th Congress of the European Academy of Neurology (EAN) officially opened in Helsinki, welcoming an enthusiastic community of neurologists, researchers and clinicians from across the globe. -
Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for June 2025. -
EAN NewsResident and Research FellowsTransformative year will “reshape our section of the society” says former RRFS Chair
Former EAN Residents & Research Fellows Section Chair, Giacomo Sferruzza looks back on a year of transformative events for the rapidly growing community. -
EAN NewsKeeping the past for the future – long serving archivists step down and welcome a new EAN historian
When the EAN was founded in 2014, the 1st EAN President Günther Deuschl decided that we should have an EAN archive. He invited two members of the mother societies ENS and EFNS to volunteer as “historians” and become the first… Continue Reading -
Executive PageEAN NewsEAN Congress newsFeatured SliderExecutive Page: Get ready for EAN 2025 in Helsinki!
EAN Programme Committee Chair, Irena Rektorová, & EAN President, Elena Moro preview some major highlights of the EAN Congress 2025, taking place in Helsinki in just a few weeks. -
Welcome to the June 2025 edition of the President’s Corner, our article series in which the EAN President, Elena Moro, answers your questions! -
Paper of the MonthEAN NewsFeatured SliderResearch Papers of the Month: Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease / Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson’s disease
Our papers of the month for June are two studies that suggest that transplantation of dopaminergic progenitor cells into the striatum may confer meaningful clinical benefits for patients with Parkinson’s disease. -
Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for May 2025.
-
Together with the Brain Health Mission, the EAN is excited to announce the launch of the Public Brain Health Day, on Monday, 23 June 2025, during the 11th EAN Congress in Helsinki. -
Brain HealthEAN News9th ESF Sleep Medicine School offers creative insights into sleep and brain health
The University of Cyprus in Nicosia was thrilled to host the highly anticipated 9th European Sleep Foundation (ESF) Sleep Medicine School from 31 March to 3 April 2025, endorsed by the EAN. -
Executive PageEAN NewsFeatured SliderExecutive Page: panels, guidelines, EBRAINS, and more ways to get involved in EAN scientific activities
EAN Scientific Committee Chair, Gereon R. Fink, provides a look at various ongoing projects, including a variety of ways you can contribute to EAN scientific activities. -
Welcome to the May 2025 edition of the President’s Corner, our article series in which the EAN President, Elena Moro, answers your questions!
-
Paper of the MonthEAN NewsFeatured Slider
Research Papers of the Month: Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis / Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis
Our papers of the month for May are two papers present findings from recent trials evaluating the efficacy and safety of tolebrutinib in patients with multiple sclerosis.
Newer Posts